Literature DB >> 16960789

Chloroquine prevents T lymphocyte suppression induced by anthrax lethal toxin.

Mark I Hirsh1, Victoria Cohen.   

Abstract

Lysosomal processing of lethal toxin (LTX) is a key event in the pathogenesis of anthrax. This study investigated the ability of chloroquine (CQ) to interfere with this processing and thereby to reduce suppression of T lymphocytes. T lymphocytes isolated from blood were activated, by cross-linking of CD3, in both the absence and presence of LTX and CQ and then were assayed by flow cytometry and immunoblotting. LTX was found to disrupt intracellular signaling, and it down-regulated T lymphocyte function. CQ significantly reduced the harmful effects of LTX and protected the activation and cytokine production of T lymphocytes. This effect may indicate a promising strategy in the treatment of anthrax.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16960789     DOI: 10.1086/507311

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  3 in total

Review 1.  An overview of investigational toxin-directed therapies for the adjunctive management of Bacillus anthracis infection and sepsis.

Authors:  Lernik Ohanjanian; Kenneth E Remy; Yan Li; Xizhong Cui; Peter Q Eichacker
Journal:  Expert Opin Investig Drugs       Date:  2015-04-28       Impact factor: 6.206

2.  Amiodarone and bepridil inhibit anthrax toxin entry into host cells.

Authors:  Ana M Sanchez; Diane Thomas; Eugene J Gillespie; Robert Damoiseaux; Joseph Rogers; Jonathan P Saxe; Jing Huang; Marianne Manchester; Kenneth A Bradley
Journal:  Antimicrob Agents Chemother       Date:  2007-05-07       Impact factor: 5.191

3.  Two anthrax cases with soft tissue infection, severe oedema and sepsis in Danish heroin users.

Authors:  Lene Russell; Michael Pedersen; Andreas V Jensen; Lillian Marie Søes; Ann-Brit Eg Hansen
Journal:  BMC Infect Dis       Date:  2013-09-03       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.